NCAM2 and Alzheimer disease: Moreover, compared to the control group, AD and COVID-19 were associated with a significantly reduced percentage of cluster 3 characterized by neural cell adhesion molecule 1 (NCAM1), neural cell adhesion molecule 2 (NCAM2), and glial fibrillary acidic protein (GFAP) (Figures 2B, C).